Fig. 3From: The reduction in CD8+PD-1+ T cells in liver histological tissue is related to Pegylated IFN-α therapy outcomes in chronic hepatitis B patientsThe changes in CD8+PD-1+ T cells and CD8+PD-1− T cells at baseline and post-treatment. a: Representative images of CD8+PD-1+ T cells and CD8+PD-1− T cells on the same slide from sample of case 231,167 evaluated by multiplex immunohistochemical staining. 400× magnification. PID: Patient ID. b-d: The changes in the levels of CD8+ T cells, CD8+PD-1+ T cells, and CD8+PD-1− T cells at baseline and post-treatment in the FIER groups (n = 7). e-g: The changes in the levels of CD8+ T cells, CD8+PD-1+ T cells and CD8+PD-1− T cells at baseline and post-treatment in the FIENR groups (n = 9)Back to article page